AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
AMLODIPINE BESILATE; VALSARTAN in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ZETAKARDOVAL 10/160 TABLET, COATED; ORAL | 2024/12.3.5/6728 | ORANGE HEALTH P/L | active | 17 Oct 2029 |
| ZETAKARDOVAL 5/160 TABLET, COATED; ORAL | 2024/12.3.5/6727 | ORANGE HEALTH P/L | active | 17 Oct 2029 |
| STARVAL-AM 10/160 TABLET, COATED; ORAL | 2017/12.3.5/5316 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | active | 1 May 2029 |
| VALPLUS 5+ TABLET, COATED; ORAL | 2024/12.3.5/6589 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| VALMAC A 160/5 TABLET, COATED; ORAL | 2024/12.3.5/6637 | MACLEODS PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
AMLODIPINE BESILATE; VALSARTAN — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing AMLODIPINE BESILATE; VALSARTAN, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track AMLODIPINE BESILATE; VALSARTAN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.